vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Valens Semiconductor Ltd. (VLN). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $17.3M, roughly 1.8× Valens Semiconductor Ltd.). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -42.2%, a 10.1% gap on every dollar of revenue. On growth, Valens Semiconductor Ltd. posted the faster year-over-year revenue change (8.1% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-4.9M).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Valens Semiconductor (Valens) is an Israeli fabless manufacturing company providing semiconductors for the automotive and audio-video industries. Valens provides semiconductor products for the distribution of uncompressed ultra-high-definition (UHD) multimedia content and in-vehicle connectivity applications. The company is a member of the MIPI Alliance and developed the first-to-market chipset that is compliant with the MIPI A-PHY standard. Valens invented the technology behind the HDBaseT s...
LFCR vs VLN — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $17.3M |
| Net Profit | $-10.0M | $-7.3M |
| Gross Margin | 25.0% | 63.0% |
| Operating Margin | -9.9% | -46.4% |
| Net Margin | -32.1% | -42.2% |
| Revenue YoY | -4.5% | 8.1% |
| Net Profit YoY | -52.0% | 29.3% |
| EPS (diluted) | $-0.29 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $31.1M | $17.3M | ||
| Q2 25 | — | $17.1M | ||
| Q1 25 | $35.2M | $16.8M | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $24.7M | $16.0M | ||
| Q2 24 | — | $13.6M | ||
| Q1 24 | $35.7M | — | ||
| Q4 23 | $30.1M | — |
| Q3 25 | $-10.0M | $-7.3M | ||
| Q2 25 | — | $-7.2M | ||
| Q1 25 | $-14.8M | $-8.3M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-16.2M | $-10.4M | ||
| Q2 24 | — | $-8.9M | ||
| Q1 24 | $15.6M | — | ||
| Q4 23 | $14.2M | — |
| Q3 25 | 25.0% | 63.0% | ||
| Q2 25 | — | 63.5% | ||
| Q1 25 | 28.0% | 62.9% | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | 56.4% | ||
| Q2 24 | — | 61.4% | ||
| Q1 24 | 33.3% | — | ||
| Q4 23 | 33.0% | — |
| Q3 25 | -9.9% | -46.4% | ||
| Q2 25 | — | -43.3% | ||
| Q1 25 | -25.7% | -56.2% | ||
| Q4 24 | -6.0% | — | ||
| Q3 24 | -46.9% | -76.3% | ||
| Q2 24 | — | -69.2% | ||
| Q1 24 | -2.5% | — | ||
| Q4 23 | -4.9% | — |
| Q3 25 | -32.1% | -42.2% | ||
| Q2 25 | — | -42.1% | ||
| Q1 25 | -42.0% | -49.4% | ||
| Q4 24 | -20.2% | — | ||
| Q3 24 | -65.7% | -64.6% | ||
| Q2 24 | — | -65.2% | ||
| Q1 24 | 43.8% | — | ||
| Q4 23 | 47.2% | — |
| Q3 25 | $-0.29 | $-0.07 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | $-0.47 | $-0.08 | ||
| Q4 24 | $-0.25 | — | ||
| Q3 24 | $-0.53 | $-0.10 | ||
| Q2 24 | — | $-0.08 | ||
| Q1 24 | $0.42 | — | ||
| Q4 23 | $0.39 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $93.5M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $108.8M |
| Total Assets | $235.2M | $136.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $18.9M | $93.5M | ||
| Q2 25 | — | $102.7M | ||
| Q1 25 | $5.4M | $112.5M | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | $133.1M | ||
| Q2 24 | — | $105.9M | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — | ||
| Q4 23 | $92.9M | — |
| Q3 25 | $-10.5M | $108.8M | ||
| Q2 25 | — | $116.5M | ||
| Q1 25 | $2.2M | $128.6M | ||
| Q4 24 | $15.4M | — | ||
| Q3 24 | $-3.9M | $147.0M | ||
| Q2 24 | — | $153.5M | ||
| Q1 24 | $17.7M | — | ||
| Q4 23 | $1.4M | — |
| Q3 25 | $235.2M | $136.7M | ||
| Q2 25 | — | $144.8M | ||
| Q1 25 | $237.7M | $154.6M | ||
| Q4 24 | $255.4M | — | ||
| Q3 24 | $246.8M | $171.9M | ||
| Q2 24 | — | $175.8M | ||
| Q1 24 | $246.2M | — | ||
| Q4 23 | $245.8M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — | ||
| Q4 23 | 65.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-4.7M |
| Free Cash FlowOCF − Capex | $25.0K | $-4.9M |
| FCF MarginFCF / Revenue | 0.1% | -28.5% |
| Capex IntensityCapex / Revenue | 5.6% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $-11.0M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $1.8M | $-4.7M | ||
| Q2 25 | — | $-211.0K | ||
| Q1 25 | $1.2M | $-7.6M | ||
| Q4 24 | $-6.1M | — | ||
| Q3 24 | $-613.0K | $3.0M | ||
| Q2 24 | — | $-225.0K | ||
| Q1 24 | $-1.4M | — | ||
| Q4 23 | $1.3M | — |
| Q3 25 | $25.0K | $-4.9M | ||
| Q2 25 | — | $-330.0K | ||
| Q1 25 | $-4.3M | $-8.0M | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | $2.2M | ||
| Q2 24 | — | $-460.0K | ||
| Q1 24 | $-7.8M | — | ||
| Q4 23 | $-3.0M | — |
| Q3 25 | 0.1% | -28.5% | ||
| Q2 25 | — | -1.9% | ||
| Q1 25 | -12.1% | -47.3% | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | 14.0% | ||
| Q2 24 | — | -3.4% | ||
| Q1 24 | -21.8% | — | ||
| Q4 23 | -9.9% | — |
| Q3 25 | 5.6% | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | 15.5% | 2.1% | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | 4.5% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | 17.8% | — | ||
| Q4 23 | 14.1% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — | ||
| Q4 23 | 0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
VLN
Segment breakdown not available.
